[1] WYNANTS L,VAN CALSTER B,COLLINS G S,et al. Prediction models for diagnosis and prognosis of COVID-19:systematic review and critical appraisal[J/OL]. BMJ,2020,369[2023-01-15]. https://doi.org/10.1136/bmj.m1328.
[2] VAN SMEDEN M. The definitive guide to COVID-19 prognosis modeling success 2020[EB/OL]. [2023-03-28]. https://twitter.com/MaartenvSmeden/status/1262854476576194566.
[3] COLLINS G S,REITSMA J B,ALTMAN D G,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis(TRIPOD):the TRIPOD statement[J]. Ann Intern Med,2015,162(1):55-63.
[4] MOONS K G,ALTMAN D G,REITSMA J B,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis(TRIPOD):explanation and elaboration[J/OL]. Ann Intern Med,2015,162(1):W1-W73[2023-01-15]. https://doi.org/10.7326/M14-0698.
[5] WOLFF R F,MOONS K G,RILEY R D,et al. PROBAST:a tool to assess the risk of bias and applicability of prediction model studies[J]. Ann Intern Med,2019,170(1):51-58.
[6] MOONS K G M,WOLFF R F,RILEY R D,et al. PROBAST:a tool to assess risk of bias and applicability of prediction model studies:explanation and elaboration[J/OL]. Ann Intern Med,2019,170(1):W1-W33[2023-01-11]. https://doi.org/10.7326/M18-1377.
[7] ELDREDGE J D,WEAGEL E F,KROTH P J. Defining and identifying members of a research study population:CTSA-affiliated faculty members[J]. Hypothesis(Macon),2014,26(1):5-11.
[8] VAN GELOVEN N,SWANSON S A,RAMSPEK C L,et al. Prediction meets causal inference:the role of treatment in clinical prediction models[J]. Eur J Epidemiol,2020,35(7):619-630.
[9] PAJOUHESHNIA R,DAMEN J A A G,GROENWOLD R H H,et al. Treatment use in prognostic model research:a systematic review of cardiovascular prognostic studies[J/OL]. Diagn Progn Res,2017,1:15[2023-01-15]. https://doi.org/10.1186/s41512-017-0015-0.
[10] PROSEPE I,GROENWOLD R H,KNEVEL R,et al. The disconnect between development and intended use of clinical prediction models for COVID-19:a systematic review and real-world data illustration[J/OL]. Front Epidemiol,2022[2023-01-15]. https://doi.org/10.3389/fepid.2022.899589.
[11] WHITTLE R,PEAT G,BELCHER J,et al. Measurement error and timing of predictor values for multivariable risk prediction models are poorly reported[J/OL]. J Clin Epidemiol,2018,102:38-49[2023-01-15]. https://doi.org/10.1016/j.jclinepi.2018.05.008.
[12] WHITTLE R,ROYLE K L,JORDAN K P,et al. Prognosis research ideally should measure time-varying predictors at their intended moment of use[J/OL]. Diagn Progn Res,2017,1:1[2023-01-15]. https://doi.org/10.1186/s41512-016-0006-6.
[13] OREŠKI G. An experimental comparison of classification algorithm performances for highly imbalanced datasets[C/OL]. Varaždin:25th Central European Conference on Information and Intelligent Systems,2014[2023-01-15]. https://xueshu.baidu.com/usercenter/paper/show?paperid=536441dc81b241ecc707d1c1fdf206d3&site=xueshu_se.
[14] JENI L A,COHN J F,DE LA TORRE F. Facing imbalanced data--recommendations for the use of performance metrics[C/OL]. Geneva:2013 Humaine Association Conference on Affective Computing and Intelligent Interaction,2013[2023-01-15]. https://xueshu.baidu.com/usercenter/paper/show?paperid=03a678e7b91668b70d17b4a502741f92&site=xueshu_se&hitarticle=1.
[15] CHOWDHURY M Z I,TURIN T C. Variable selection strategies and its importance in clinical prediction modelling[J/OL]. Fam Med Community Health,2020,8(1):e000262[2023-01-15]. https://doi.org/10.1136/fmch-2019-000262.
[16] RAMSPEK C L,JAGER K J,DEKKER F W,et al. External validation of prognostic models:what,why,how,when and where?[J]. Clin Kidney J,2020,14(1):49-58.
[17] RILEY R D,ENSOR J,SNELL K I E,et al. Calculating the sample size required for developing a clinical prediction model[J/OL]. BMJ,2020,368:m441[2023-01-15]. https://doi.org/10.1136/bmj.m441.
[18] PEDUZZI P,CONCATO J,KEMPER E,et al. A simulation study of the number of events per variable in logistic regression analysis[J]. J Clin Epidemiol,1996,49(12):1373-1379.
[19] ARCHER L,SNELL K I E,ENSOR J,et al. Minimum sample size for external validation of a clinical prediction model with a continuous outcome[J]. Stat Med,2021,40(1):133-146.
[20] RILEY R D,DEBRAY T P A,COLLINS G S,et al. Minimum sample size for external validation of a clinical prediction model with a binary outcome[J]. Stat Med,2021,40(19):4230-4251.
[21] RILEY R D,COLLINS G S,ENSOR J,et al. Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome[J]. Stat Med,2022,41(7):1280-1295.
[22] HAJIAN-TILAKI K. Receiver operating characteristic(ROC)curve analysis for medical diagnostic test evaluation[J]. Caspian J Intern Med,2013,4(2):627-635.
[23] YING X. An overview of overfitting and its solutions[C/OL]. Bristol:IOP Publishing,2019[2023-01-15]. https://doi.org/10.1088/1742-6596/1168/2/022022.
[24] KOHAVI R,SOMMERFIELD D. Feature subset selection using the wrapper method:overfitting and dynamic search space topology[C/OL]. Palo Alto:AAAI Press,1995[2023-01-15]. https://xueshu.baidu.com/usercenter/paper/show?paperid=625841482e213ca48a1f651f0cbbf474&site=xueshu_se&hitarticle=1.
[25] SRIVASTAVA N,HINTON G,KRIZHEVSKY A,et al. Dropout:a simple way to prevent neural networks from overfitting[J]. J Mach Learn Res,2014,15(1):1929-1958.
[26] DAEE P,PELTOLA T,VEHTARI A,et al. User modelling for avoiding overfitting in interactive knowledge elicitation for prediction[C/OL]. Tokyo:23rd International Conference on Intelligent User Interfaces,2018[2023-01-15]. https://doi.org/10.1145/3172944.3172989.
[27] FARRINGTON D P,LOEBER R. Some benefits of dichotomization in psychiatric and criminological research[J]. Crim Behav Ment Health,2010,10(2):100-122.
[28] CHEN H N,COHEN P,CHEN S. Biased odds ratios from dichotomization of age[J]. Stat Med,2007,26(18):3487-3497.
[29] AUSTIN P C,BRUNNER L J. Inflation of the type Ⅰ error rate when a continuous confounding variable is categorized in logistic regression analyses[J]. Stat Med,2004,23(7):1159-1178.
[30] KWAK S K,KIM J H. Statistical data preparation:management of missing values and outliers[J]. Korean J Anesthesiol,2017,70(4):407-411.
[31] DONDERS A R T,VAN DER HEIJDEN G J,STIJNEN T,et al. Review:a gentle introduction to imputation of missing values[J]. J Clin Epidemiol,2006,59(10):1087-1091.
[32] KANG H. The prevention and handling of the missing data[J]. Korean J Anesthesiol,2013,64(5):402-406.
[33] NATTINO G,PENNELL M L,LEMESHOW S. Assessing the goodness of fit of logistic regression models in large samples:a modification of the Hosmer-Lemeshow test[J]. Biometrics,2020,76(2):549-560.
[34] PAUL P,PENNELL M L,LEMESHOW S. Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets[J]. Stat Med,2013,32(1):67-80.
[35] EVERITT B,HOWELL D. Encyclopedia of Statistics in Behavioral Science[M]. New York:Wiley,2005.
[36] MOONS K G,ALTMAN D G,REITSMA J B,et al. New guideline for the reporting of studies developing,validating,or updating a multivariable clinical prediction model:the TRIPOD statement[J]. Adv Anat Pathol,2015,22(5):303-305.
[37] HEUS P,DAMEN J A A G,PAJOUHESHNIA R,et al. Poor reporting of multivariable prediction model studies:towards a targeted implementation strategy of the TRIPOD statement[J/OL]. BMC Med,2018,16(1):120[2023-01-15]. https://doi.org/10.1186/s12916-018-1099-2.
[38] LU J H,CALLAHAN A,PATEL B S,et al. Assessment of adherence to reporting guidelines by commonly used clinical prediction models from a single vendor:a systematic review[J/OL]. JAMA Netw Open,2022,5(8):e2227779[2023-01-15]. https://doi.org/10.1001/jamanetworkopen.2022.27779.
[39] ALTMAN D G,VERGOUWE Y,ROYSTON P,et al. Prognosis and prognostic research:validating a prognostic model[J/OL]. BMJ,2009,338:b605[2023-01-15]. https://doi.org/10.1136/bmj.b605.
[40] CRADDOCK M,CROCKETT C,MCWILLIAM A,et al. Evaluation of prognostic and predictive models in the oncology clinic[J]. Clin Oncol,2022,34(2):102-113.
[41] BLEEKER S E,MOLL H A,STEYERBERG E W,et al. External validation is necessary in prediction research:a clinical example[J]. J Clin Epidemiol,2003,56(9):826-832.
[42] CAMPAGNER A,CAROBENE A,CABITZA F. External validation of machine learning models for COVID-19 detection based on complete blood count[J/OL]. Health Inf Sci Syst,2021,9(1):37[2023-01-15]. https://doi.org/10.1007/s13755-021-00167-3.
[43] REPS J M,KIM C,WILLIAMS R D,et al. Can we trust the prediction model? Demonstrating the importance of external validation by investigating the COVID-19 vulnerability(C-19)index across an international network of observational healthcare datasets[J/OL]. medRxiv,2020[2023-01-15]. https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1.
[44] MARTENS F K,KERS J G,JANSSENS A C J. External validation is only needed when prediction models are worth it(Letter commenting on:J Clin Epidemiol. 2015; 68:25-34)[J/OL]. J Clin Epidemiol,2016,69:249-250[2023-01-20]. https://doi.org/10.1016/j.jclinepi.2015.01.022.
[45] STEYERBERG E W,BLEEKER S E,MOLL H A,et al. Internal and external validation of predictive models:a simulation study of bias and precision in small samples[J]. J Clin Epidemiol,2003,56(5):441-447.
[46] KÖNIG I R,MALLEY J D,WEIMAR C,et al. Practical experiences on the necessity of external validation[J]. Stat Med,2007,26(30):5499-5511.
[47] LOMBARDI Y,AZOYAN L,SZYCHOWIAK P,et al. External validation of prognostic scores for COVID-19:a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals[J]. Intensive Care Med,2021,47(12):1426-1439.